NO20071824L - Fremgangsmater til a behandle trakeale, bronkiale eller alveolaere blodninger eller hemoptyse - Google Patents

Fremgangsmater til a behandle trakeale, bronkiale eller alveolaere blodninger eller hemoptyse

Info

Publication number
NO20071824L
NO20071824L NO20071824A NO20071824A NO20071824L NO 20071824 L NO20071824 L NO 20071824L NO 20071824 A NO20071824 A NO 20071824A NO 20071824 A NO20071824 A NO 20071824A NO 20071824 L NO20071824 L NO 20071824L
Authority
NO
Norway
Prior art keywords
bronchial
hemoptysis
methods
tracheal
alveolar hemorrhage
Prior art date
Application number
NO20071824A
Other languages
English (en)
Norwegian (no)
Inventor
Lars Heslet
Lars Otto Uttenthal
Original Assignee
Pharmaorigin Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaorigin Aps filed Critical Pharmaorigin Aps
Publication of NO20071824L publication Critical patent/NO20071824L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20071824A 2004-09-10 2007-04-10 Fremgangsmater til a behandle trakeale, bronkiale eller alveolaere blodninger eller hemoptyse NO20071824L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60875904P 2004-09-10 2004-09-10
US62297704P 2004-10-28 2004-10-28
US69396905P 2005-06-24 2005-06-24
PCT/DK2005/000576 WO2006026998A1 (en) 2004-09-10 2005-09-09 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis

Publications (1)

Publication Number Publication Date
NO20071824L true NO20071824L (no) 2007-04-10

Family

ID=35482229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071824A NO20071824L (no) 2004-09-10 2007-04-10 Fremgangsmater til a behandle trakeale, bronkiale eller alveolaere blodninger eller hemoptyse

Country Status (13)

Country Link
US (2) US8431535B2 (es)
EP (1) EP1791555B1 (es)
JP (2) JP2008512403A (es)
KR (1) KR101241434B1 (es)
AU (1) AU2005282065B2 (es)
BR (1) BRPI0515163A (es)
CA (1) CA2579884C (es)
DK (1) DK1791555T3 (es)
HK (1) HK1104970A1 (es)
IL (1) IL181824A (es)
MX (1) MX2007002903A (es)
NO (1) NO20071824L (es)
WO (1) WO2006026998A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007002903A (es) 2004-09-10 2007-07-11 Pharmaorigin Aps Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales.
US8088728B2 (en) * 2005-06-24 2012-01-03 Drugrecure Aps Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract
US20070225749A1 (en) 2006-02-03 2007-09-27 Martin Brian B Methods and devices for restoring blood flow within blocked vasculature
WO2007104317A1 (en) * 2006-03-16 2007-09-20 Drugrecure Aps Methods for local treatment with factor vii
WO2010102307A1 (en) 2009-03-06 2010-09-10 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
US20120141467A1 (en) * 2010-12-03 2012-06-07 Schneider Daniel J Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma
US9301936B2 (en) 2013-07-08 2016-04-05 Imprimis Pharmaceuticals, Inc. Pharmaceutical formulations of tranexamic acid and their use
US10456560B2 (en) 2015-02-11 2019-10-29 Covidien Lp Expandable tip medical devices and methods

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920845A (en) * 1971-08-03 1975-11-18 Beecham Group Ltd 2-nitroindan-1,3-dione
US5096916A (en) 1990-05-07 1992-03-17 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5427797A (en) * 1993-04-06 1995-06-27 Brigham And Women's Hospital Systemic effects of nitric oxide inhalation
US5980865A (en) 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US5690910A (en) * 1995-08-18 1997-11-25 Baker Norton Pharmaceuticals, Inc. Method for treating asthma
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
WO1998032459A1 (en) * 1997-01-29 1998-07-30 University Technology Corporation Plasminogen activator as an anti-inflammatory agent
AP1342A (en) * 1998-03-16 2004-12-15 Nektar Therapeutics Aerosolized active agent delivery.
DE69928279T2 (de) * 1998-11-10 2006-08-17 Altana Pharma Ag Lungensurfactant zubereitungen enthaltendes behandlungset
WO2001085199A1 (en) * 2000-05-10 2001-11-15 Novo Nordisk A/S PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR
US7419949B2 (en) * 2001-07-16 2008-09-02 Novo Noridsk Healthcare A/G Single-dose administration of factor VIIa
EP1446147A1 (en) * 2001-11-09 2004-08-18 Novo Nordisk Health Care AG Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
EP1474439B1 (en) * 2002-02-04 2009-05-06 Salpep Biotechnology Inc. Dipeptides and tripeptides with anti-inflammatory activity
KR101036058B1 (ko) * 2002-04-25 2011-05-19 더 스크립스 리서치 인스티튜트 폐질환 증상의 치료 및 예방
US7700733B2 (en) * 2002-04-30 2010-04-20 Bayer Healthcare Llc Factor VII or VIIa polypeptide variants
EP1617799A2 (en) * 2003-04-09 2006-01-25 Wyeth Hemophilia treatment by inhalation of coagulation factors
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US7404957B2 (en) * 2003-08-29 2008-07-29 Aerovance, Inc. Modified IL-4 mutein receptor antagonists
MX2007002903A (es) 2004-09-10 2007-07-11 Pharmaorigin Aps Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales.

Also Published As

Publication number Publication date
AU2005282065A1 (en) 2006-03-16
AU2005282065B2 (en) 2013-02-07
WO2006026998A8 (en) 2006-05-04
EP1791555A1 (en) 2007-06-06
CA2579884C (en) 2013-12-31
US20070258971A1 (en) 2007-11-08
KR20070067127A (ko) 2007-06-27
JP5537537B2 (ja) 2014-07-02
KR101241434B1 (ko) 2013-03-12
US20070060517A1 (en) 2007-03-15
EP1791555B1 (en) 2013-03-13
IL181824A (en) 2012-05-31
JP2008512403A (ja) 2008-04-24
BRPI0515163A (pt) 2008-07-08
MX2007002903A (es) 2007-07-11
US8431535B2 (en) 2013-04-30
DK1791555T3 (da) 2013-06-10
US7807639B2 (en) 2010-10-05
HK1104970A1 (en) 2008-02-01
WO2006026998A1 (en) 2006-03-16
IL181824A0 (en) 2007-07-04
JP2012092131A (ja) 2012-05-17
CA2579884A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
NO20071824L (no) Fremgangsmater til a behandle trakeale, bronkiale eller alveolaere blodninger eller hemoptyse
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
BRPI0513866A (pt) composição, micropartìculas, método para o tratamento da hipertensão pulmonar, e dispositivo de inalação
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
UA108193C2 (uk) Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
ATE455463T1 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
PH12018500641A1 (en) Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
ATE489105T1 (de) Faktor ixa zur behandlung von blutungsstörungen
NO20083658L (no) Cyanoisokinolinforbindelser som stabiliserer hypoksi induserbar faktor(HIF)
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
NO20092637L (no) Fremgangsmater for behandling
NO20062876L (no) Sammensetninger til kombinert radio- og kjemoterapi, og fremgangsmater
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
DK2029184T3 (da) Injicerbar fibrinsammensætning til knogleforstærkning
SG196863A1 (en) Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
WO2008049056A3 (en) Treatment of medical condition with a2 domain of von willebrand factor
WO2004075838A3 (en) Method and compositions for the treatment of meconium aspiration syndrome
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
TW200507840A (en) Method of treating multiple myeloma
CY1120487T1 (el) Νεα μεθοδος για τη θεραπεια λοιμωξεων απο ελικοβακτηριδιο του πυλωρου (η. pylori)
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE475408T1 (de) Formulierungen von tipifarnib zur intravenösen verabreichung
WO2009049234A3 (en) Methods of treating coagulopathy
TW200503716A (en) Treatment of bacterial diseases of the respiratory organs

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application